Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PD-1 regulates CD4<sup>+</sup> T cell-mediated CD8<sup>+</sup> T cell responses in the brain to balance viral control and neuroinflammation.

Research square·2026
Same author

PD-1 regulates CD4<sup>+</sup> T cell-mediated CD8<sup>+</sup> T cell responses in the brain to balance viral control and neuroinflammation.

bioRxiv : the preprint server for biology·2025
Same author

Live long and persist: polyomavirus immune evasion in the brain and kidney.

Future virology·2025
Same author

The CXCR6-CXCL16 axis mediates T cell control of polyomavirus infection in the kidney.

PLoS pathogens·2025
Same author

The CD4 T cell-independent IgG response during persistent virus infection favors emergence of neutralization-escape variants.

bioRxiv : the preprint server for biology·2025
Same author

Brincidofovir inhibits polyomavirus infection <i>in vivo</i>.

mBio·2024

Related Experiment Video

Updated: Nov 1, 2025

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.2K

Understanding polyomavirus CNS disease - a perspective from mouse models.

Katelyn N Ayers1, Sarah N Carey1, Aron E Lukacher1

  • 1Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, USA.

The FEBS Journal
|June 19, 2021
PubMed
Summary

A new mouse model using mouse polyomavirus (MuPyV) helps study JC polyomavirus (JCPyV) brain infections. This model aids in understanding immune responses and developing treatments for progressive multifocal leukoencephalopathy (PML).

Keywords:
antibody-escape virusesbrain-resident memory T cellsneuroinflammationpolyomavirus

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.8K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.8K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human &#945;-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.2K

Area of Science:

  • Neurovirology
  • Immunology
  • Infectious Diseases

Background:

  • JC polyomavirus (JCPyV) causes fatal brain diseases like progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals.
  • PML is a risk for multiple sclerosis patients on natalizumab and other immunomodulatory therapies.
  • Current treatment options for PML are limited, and no anti-JCPyV agents exist.

Purpose of the Study:

  • To address the lack of a suitable animal model for studying JCPyV-associated central nervous system (CNS) diseases.
  • To explore the benefits of the natural virus-host mouse polyomavirus (MuPyV) model for understanding JCPyV pathogenesis.
  • To investigate immune control mechanisms and the impact of immunomodulation on JCPyV CNS disease.

Main Methods:

  • Utilizing the established mouse polyomavirus (MuPyV) model to mimic JCPyV-induced CNS disease.
  • Investigating innate and adaptive immune responses to polyomavirus infection in the CNS.
  • Evaluating the effects of immunomodulatory agents on polyomavirus pathogenesis and disease progression.

Main Results:

  • The MuPyV model provides a tractable system for studying polyomavirus-induced CNS pathology.
  • This model allows for in vivo assessment of immune responses crucial for controlling JCPyV.
  • It facilitates the evaluation of potential therapeutic strategies against JCPyV replication.

Conclusions:

  • The MuPyV CNS infection model is essential for advancing research into JCPyV-associated diseases like PML.
  • This model will improve understanding of immune-mediated control of JCPyV.
  • It holds promise for developing better diagnostic criteria and therapeutic interventions for patients at risk of JCPyV-related neuropathology.